Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis: Prognostic Significance
Sponsor: Istanbul University - Cerrahpasa
Listed as NCT05452850, this observational or N/A phase trial focuses on Amyloid Cardiomyopathy and Chemotherapy Effect and remains ongoing. Sponsored by Istanbul University - Cerrahpasa, it has been updated 8 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Nov 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2025 — Nov 2025 [monthly]
Active Not Recruiting
-
Jan 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 3 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2023 — Oct 2023 [monthly]
Recruiting
-
Sep 2022 — Feb 2023 [monthly]
Recruiting
First recorded
Aug 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Istanbul University - Cerrahpasa
For direct contact, visit the study record on ClinicalTrials.gov .